FindTrial
Sign In

Acceptability, safety, pharmacokinetics and effects on blood pressure of a daily dose of 0.025 to 0.135 milligram per kilogram of S 90652, a paediatric formulation of perindopril, in 2-16 years old hypertensive children - an open, non-comparative, 3-month multicentre study

Acceptability, safety, pharmacokinetics and effects on blood pressure of a daily dose of 0.025 to 0.135 milligram per kilogram of S 90652, a paediatric formulation of perindopril, in 2-16 years old hypertensive children - an open, non-comparative, 3-month multicentre study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-000077-22-IT
Enrollment
Unknown
Registered
2005-09-02
Start date
2005-10-11
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial Hypertension MedDRA version: 6.1 Level: PT Classification code 10015488

Interventions

Product Name: perindopril Product Code: S 90652 Pharmaceutical Form: Compressed lozenge INN or Proposed INN: Perindopril Concentration unit: µg microgram(s) Concentration type: equal Concentration num

Sponsors

INSTITUT DE RECHERCHES INTERNATIONALES SERVIER
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026